HOLOGIC INC — Director's Dealing 2012

Aug 2, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HOLOGIC INC (HOLX)
CIK: 0000859737
Period of Report: 2012-08-01

Reporting Person: HULL CARL (SVP and GM of Diagnostics)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-qualified Stock Option (Right to Buy)	$15.35	2019-02-10	Common Stock (496292)		Direct

Footnotes

F1: Pursuant to the Agreement and Plan of Merger by and among Gen-Probe Incorporated ("Gen-Probe"), Hologic, Inc. ("Hologic") and Gold Acquisition Corp. dated as of April 29, 2012 and filed with the Securities and Exchange Commission of Form 8-K on May 1, 2012 ("Agreement"), the option previously issued to the Reporting Person by Gen-Probe on February 10, 2012 (110,000 shares at grant price of $69.22) shall be assumed by Hologic in accordance with the Option Exchange Ratio (conversion rate 4.51174963) and shall continue to have, and be subject to, the same terms and conditions, including vesting, applicable to such option immediately prior to the effective time of the merger.